Cannabis is prohibited in South Korea. A patient can use a cannabis-based medicine approved abroad only with case-by-case approval from the Ministry of Food and Drug Safety (MFDS). CBD itself counts as cannabis, and Korean law follows Korean nationals abroad, including to Thailand.
The short answer
- Recreational use: banned, with up to 5 years in prison or a fine of up to 50 million won.
- Medical cannabis: only finished medicines approved by a foreign regulator, imported for one patient at a time. There is no flower programme.
- CBD and hemp: CBD is cannabis, whatever its THC content. Licensed farmers may grow hemp for fibre and seed.
- Penalties: importing or exporting cannabis carries life imprisonment or at least 5 years. For profit or as a habit, the court may impose the death penalty.
- Travel: cannabis and CBD products may not be brought in. Korean citizens can be punished at home for using cannabis abroad.
The laws that apply
- Narcotics Control Act (마약류 관리에 관한 법률), first enacted on 12 January 2000. The version in force is Act No. 21102, promulgated on 11 November 2025 and in force since 12 November 2026; it did not change the cannabis rules.
- Act No. 15939, promulgated on 11 December 2018, added “medical purposes” to the cannabis exceptions. These provisions took effect on 12 March 2019.
- Enforcement Decree, Presidential Decree No. 36827. Its Annex 7-2 lists cannabinol (CBN), THC and cannabidiol (CBD) as cannabis.
- Criminal Act, Articles 2 and 3, on where Korean criminal law applies.
The MFDS approves every exception for importing, making or selling cannabis. Local mayors and county or district heads issue hemp grower licences. The legal definition of cannabis excludes seeds, roots, mature stalks and products made from them.
Medical cannabis
Article 3 allows cannabis to be handled for “public duties, academic research or medical purposes” with MFDS approval. The route is narrow. A patient with a rare or hard-to-treat disease and no alternative treatment in Korea may obtain a medicine already approved as a medicine abroad. Foods, cannabis oils and extracts that are not approved medicines are excluded.
The MFDS set out the steps on 26 January 2023. A specialist writes a diagnosis and an opinion that no domestic alternative exists. The patient applies to the MFDS for handling approval. The medicine is then imported through the Korea Orphan and Essential Drug Center, a state body for rare and essential medicines. The MFDS committed to deliver within 10 days.
The MFDS decides each case, with an expert panel for use outside the approved indication. Its 2023 notice names only one medicine, Epidiolex. Korean press reported in July 2026 that these medicines are still fully imported and not sold in ordinary pharmacies.
If you are a patient, start with the specialist’s diagnosis and opinion; the MFDS will not consider an application without them.
CBD and hemp
On 10 June 2025 the MFDS stated that cannabidiol “counts as cannabis regardless of the part of the plant it is extracted from”. The Supreme Court confirmed this on 29 May 2025 (case 2022두60776). A company had imported CBD isolate from mature stalks for cosmetics and was refused clearance. The court held that CBD is itself cannabis, even from an excluded plant part and with no THC. Changing that, it said, is for the legislature.
So no THC result makes a CBD product legal. Possessing, consuming, importing, making or selling it is banned, except under an approved exception. The MFDS temporary narcotics list also covers hexahydrocannabinol (HHC), several THC variants, cannabigerol (CBG) and nabilone.
Hemp seed may be sold as food only hulled. The food standard limits THC to 5 ppm in seeds and 10 ppm in seed oil, and CBD to 10 ppm and 20 ppm.
Farmers may grow hemp for fibre or seed with a local licence (Article 6). Since 2020, a regulation-free special zone in Gyeongbuk province lets licensed firms grow hemp and extract CBD as a pharmaceutical ingredient for export. The zone was designated again on 29 June 2026. It does not open the Korean market to CBD.
If you sell CBD in the region, do not ship any CBD product to Korea, whatever its lab report says.
Penalties
| Offence | Article | Penalty |
|---|---|---|
| Smoking, possessing, growing, transporting or using without a licence | 61 | up to 5 years, or a fine up to 50 million won |
| Making, selling or brokering cannabis, or growing it for sale | 59 | at least 1 year |
| Importing or exporting, or possessing for that purpose | 58(1) | life, or at least 5 years |
| Import or export for profit or as a habit | 58(2) | death, life, or at least 10 years |
| Giving cannabis to a minor | 58-2 | at least 2 years |
- Repeat offences carry heavier terms, and an employer is fined up to 50 million won for an employee’s offence.
- No weight threshold. The charge depends on the purpose, not the amount.
- The death penalty is at the court’s discretion. South Korea has carried out no execution since 30 December 1997. There is no caning.
- Korean nationals abroad: the Criminal Act applies to Korean nationals for crimes committed outside Korea. The Ministry of Justice said on 30 May 2024 that a Korean who smokes cannabis where it is legal still faces up to 5 years or 50 million won. In 2022, the press reported, the Ministry of Foreign Affairs gave the same warning about Thailand.
- Foreigners in Korea face the same law.
If you are a Korean citizen in Thailand, treat any cannabis food, drink or smoke as a crime you can be tried for at home.
Travelling with cannabis medicines, CBD or seeds
- Cannabis and CBD: bringing them into Korea is banned. Korean consular notices define cannabis as any product containing cannabinol, THC or CBD.
- Narcotic or psychotropic medicines: apply to the MFDS online before arrival, with a passport copy, ticket, diagnosis and prescription. The amount may cover the stay, up to 90 days. Processing takes 10 working days. Carry it in hand luggage; posted parcels are returned or destroyed. The notices give no route for cannabis medicines.
- New personal medicine rule: from 12 November 2026, travellers may carry up to six bottles or 3 months’ supply of a prescribed medicine. The notice does not mention narcotics or cannabis, and it does not replace the permit.
- Seeds: seeds are outside the definition of cannabis. Selling seeds or husks while knowing they will be smoked or eaten is still a crime.
For routes and seizure cases, read Taking Cannabis From Thailand to Other Asian Countries: Land and Air Routes, Seizures and Penalties. If you need a controlled medicine in Korea, apply for the permit at least 10 working days before you fly.
Changes under way
On 6 July 2026 lawmaker Kim Hyung-dong of the People Power Party filed a bill to amend the Narcotics Control Act. It is not law. According to the press, it would move CBD and proven medical cannabis components into the psychotropic medicine group. That would allow production and marketing approval in Korea under state control. A similar bill by Seo Mi-hwa of the Democratic Party was reported on 8 July 2026. On 2 November 2026 Kim was still urging a vote.
Until a bill passes, follow the current rule: CBD is cannabis.
Related reading on Asiannabis
- Cannabis Laws Across Asia and Key Global Markets, 2026: East Asia, South Asia, Israel and Europe (Part 2 of 2)
- Approved Cannabinoid Medicines: Nabiximols, Dronabinol and Nabilone, What Their Trials Showed and What Applies in Thailand
- Cannabis in Asia: Thailand, Japan, Korea, the Prohibition Treaties and the Partial Reversal (Part 2 of 2)
- Neighbouring countries: Cannabis Law in Japan (2026): Narcotic Status, Residual THC Limits for CBD and Medicines, Cannabis Law in China (2026): No Medical Use, CBD Controls and Criminal Thresholds, Cannabis Law in Taiwan (2026): Category 2 Narcotic, the 10 ppm THC Line and Epidyolex
References
- 마약류 관리에 관한 법률 — Korea Ministry of Government Legislation, National Law Information Center, checked 16 November 2026
- 마약류 관리에 관한 법률 — 제정·개정문 — National Law Information Center, checked 16 November 2026
- NARCOTICS CONTROL ACT — Korea Legislation Research Institute, translation of Act No. 20878, 2025
- NARCOTICS CONTROL ACT — amendment history — Korea Legislation Research Institute, checked 16 November 2026
- 칸나비디올(CBD)는 추출부위 관계없이 '대마’에 해당합니다 — Ministry of Food and Drug Safety, 10 June 2025
- ‘대마 성분 의약품’ 신속하게 뇌전증 환자에게 전달됩니다 — Ministry of Food and Drug Safety, 26 January 2023
- 대법원 제3부 판결 2022두60776 표준통관예정보고 발급거부처분 취소 — Supreme Court of Korea, 29 May 2025
- 自己治療用麻薬類医薬品の搬入許可オンライン申し込みに関するご案内 — Embassy of the Republic of Korea in Japan, 26 September 2025
- 自己治療目的麻薬類医薬品の搬入許可申し込みに関するご案内 — Consulate General of the Republic of Korea in Osaka, 23 April 2025
- 식약처-관세청, 자가 치료용 의약품 개인 휴대 반입 허용 — Ministry of Food and Drug Safety and Korea Customs Service, 11 November 2026
- 대마 합법 국가에서는 한국 사람도 대마가 합법일까? — Ministry of Justice, 30 May 2024
- CRIMINAL ACT — Korea Legislation Research Institute, translation of Act No. 15163, 2017
- Joint Letter to South Korean President Lee Jae-myung — Human Rights Watch and partner organisations including Harm Reduction International, 21 July 2025
- 부산·울산·충남 등 3차 규제자유특구 7곳 신규 지정 — Ministry of SMEs and Startups, 6 July 2020
- 수소 발전, 재활용 탄소연료 등 신기술 사업화 길 열린다 — Office for Government Policy Coordination and Ministry of SMEs and Startups, 29 June 2026
- 「식품의 기준 및 규격」 일부개정고시안 행정예고(식약처 공고 제2020-265호) — Ministry of Food and Drug Safety, 2020
- 김형동 의원, 치료용 대마 의약품 생산·공급 법적기반 마련 — Money Today, newspaper, 6 July 2026
- CBD 의료용 대마 국내 생산 논의 급물살탔다 — Korean Pharmaceutical Association News, 8 July 2026
- 이소영 중소벤처기업부 장관 안동 헴프 특구 찾아 실증성과 점검 — Kyongbuk Maeil, newspaper, 2 November 2026
- 대마초 천국된 태국…여행때 쿠키·소주·삼겹살도 주의해야 — Segye Ilbo and Newsis, newspaper, 16 August 2022
This page summarises the law as checked up to 16 November 2026. It is general information, not legal advice.